| 000 | 01403 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513060432.0 | ||
| 264 | 0 | _c19940928 | |
| 008 | 199409s 0 0 eng d | ||
| 022 | _a0360-3997 | ||
| 024 | 7 |
_a10.1007/BF01534554 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOhmi, N | |
| 245 | 0 | 0 |
_aPharmacological profile of a novel, orally active leukotriene B4 antagonist, SM-15178. _h[electronic resource] |
| 260 |
_bInflammation _cApr 1994 |
||
| 300 |
_a129-40 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAcetophenones _xpharmacology |
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xpharmacology |
| 650 | 0 | 4 |
_aChemotaxis, Leukocyte _xdrug effects |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aGuinea Pigs |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 |
_aLeukopenia _xchemically induced |
| 650 | 0 | 4 |
_aLeukotriene B4 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 |
_aNeutrophils _xdrug effects |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 700 | 1 | _aTani, C | |
| 700 | 1 | _aYamada, K | |
| 700 | 1 | _aFukui, M | |
| 773 | 0 |
_tInflammation _gvol. 18 _gno. 2 _gp. 129-40 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF01534554 _zAvailable from publisher's website |
| 999 |
_c8070222 _d8070222 |
||